Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients

Khairallah, P., Robbins‐Juarez, S., Patel, S., Shah, V., Toma, K., Fernandez, H., Dube, G. K., King, K., Mohan, S., Husain, S. A., Morris, H., & Crew, R. J. (2022). Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients. Clinical Transplantation, 37(1). Portico. https://doi.org/10.1111/ctr.14853
Authors:
Pascale Khairallah
Shelief Robbins-Juarez
Shefali Patel
Vaqar Shah
Katherine Toma
Hilda Fernandez
Geoffrey K Dube
Kristen King
Sumit Mohan
Syed Ali Husain
Heather Morris
Russell John Crew
Affiliated Authors:
Shefali Patel
Hilda Fernandez
Geoffrey K Dube
Kristen King
Sumit Mohan
Syed Ali Husain
Heather Morris
Russell John Crew
Subjects:
Author Keywords:
chronic active antibody mediated rejection (caamr)
donor specific antibodies
interleukin-6 (il-6)
kidney transplantation
Publication Type:
Article
Unique ID:
10.1111/ctr.14853
PMID:
Publication Date:
Data Source:
PubMed

Record Created: